No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
ZIMBABWE — Zimbabwe’s effective HIV management program has received international recognition, with the country being honored for achieving the UNAIDS set 95-95-95 HIV objectives, making it one of only three…
Read More
ZIMBABWE – TM Pick n Pay has donated US$10 million to underprivileged children diagnosed with cancer and undergoing treatment in health facilities around Harare, Zimbabwe. The donation is under the…
Read More
ZIMBABWE – The Vice President and Minister of Health and Child Care (MoHCC), Dr C.D.G.N Chiwenga has recently launched the Health Resilience Fund (HRF), a pooled donor funding mechanism which…
Read More
ZIMBABWE – Masvingo Provincial Hospital storeroom has been transformed into a new standalone microbiology laboratory by the United Kingdom’s (UK) Fleming Fund to strengthen antimicrobial resistance surveillance in Zimbabwe. In…
Read More
ZIMBABWE – Zimbabwe has secured US$633,975 from the Government of Japan for access to safe and affordable Surgical, Obstetric and Anaesthesia (SOA) care services. The funding from the Japanese Government…
Read More
ZIMBABWE – Government of Zimbabwe has adopted a ‘One Health’ approach as a guiding principle for working together to address Antimicrobial resistance (AMR). The Zimbabwe AMR Country grant consortium and…
Read More
ZIMBABWE – Ministry of Health and Child Care (MoHCC) and key stakeholders held a five-day workshop in December to update the third edition of the Zimbabwe cholera control guidelines and…
Read More
ZIMBABWE – The Ministry of Health and Child Care (MoHCC) of Zimbabwe has adopted WHO guidelines, operational handbooks and Prevent TB application mobile app as part of the Government’s efforts…
Read More
ZIMBABWE – The Republic of Zimbabwe, with support from the World Health Organization (WHO), has kickstarted a synchronized multicounty polio vaccination campaign aimed at protecting children against polio. The WHO…
Read More
ZIMBABWE – The World Health Organization (WHO) has announced that Zimbabwe has approved the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV (human immunodeficiency virus). Speaking…
Read More